Lander Egaña-Gorroño

722 total citations
17 papers, 458 citations indexed

About

Lander Egaña-Gorroño is a scholar working on Virology, Molecular Biology and Emergency Medicine. According to data from OpenAlex, Lander Egaña-Gorroño has authored 17 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Virology, 5 papers in Molecular Biology and 5 papers in Emergency Medicine. Recurrent topics in Lander Egaña-Gorroño's work include HIV Research and Treatment (7 papers), HIV-related health complications and treatments (5 papers) and Advanced Glycation End Products research (4 papers). Lander Egaña-Gorroño is often cited by papers focused on HIV Research and Treatment (7 papers), HIV-related health complications and treatments (5 papers) and Advanced Glycation End Products research (4 papers). Lander Egaña-Gorroño collaborates with scholars based in United States, Spain and Australia. Lander Egaña-Gorroño's co-authors include Ann Marie Schmidt, Alexander Shekhtman, Raquel López‐Díez, Ravichandran Ramasamy, Sergey Reverdatto, Paul F. Gugger, Gautham Yepuri, Tuixent Escribà, Mireia Arnedo and Estebán Martínez and has published in prestigious journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Lander Egaña-Gorroño

17 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lander Egaña-Gorroño United States 11 143 143 89 85 72 17 458
Saskia N. van der Crabben Netherlands 10 183 1.3× 65 0.5× 124 1.4× 126 1.5× 22 0.3× 34 626
D. Virgil Alfaro United States 15 186 1.3× 53 0.4× 28 0.3× 18 0.2× 10 0.1× 29 831
Eleni Ritou United States 11 211 1.5× 23 0.2× 41 0.5× 28 0.3× 10 0.1× 13 371
M.F. Dumon France 9 87 0.6× 17 0.1× 133 1.5× 13 0.2× 83 1.2× 15 467
Kerem Bulut Germany 14 106 0.7× 21 0.1× 172 1.9× 31 0.4× 11 0.2× 29 700
H Narbonne France 10 384 2.7× 72 0.5× 96 1.1× 5 0.1× 19 0.3× 15 563
Sandra Winning Germany 11 191 1.3× 8 0.1× 25 0.3× 250 2.9× 48 0.7× 18 608
Rivka Lederman United States 11 141 1.0× 13 0.1× 17 0.2× 48 0.6× 30 0.4× 15 328
Hangxiang Zhang China 8 157 1.1× 6 0.0× 40 0.4× 58 0.7× 39 0.5× 10 380
Laurie Bernstein United States 12 199 1.4× 370 2.6× 45 0.5× 73 0.9× 5 0.1× 32 717

Countries citing papers authored by Lander Egaña-Gorroño

Since Specialization
Citations

This map shows the geographic impact of Lander Egaña-Gorroño's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lander Egaña-Gorroño with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lander Egaña-Gorroño more than expected).

Fields of papers citing papers by Lander Egaña-Gorroño

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lander Egaña-Gorroño. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lander Egaña-Gorroño. The network helps show where Lander Egaña-Gorroño may publish in the future.

Co-authorship network of co-authors of Lander Egaña-Gorroño

This figure shows the co-authorship network connecting the top 25 collaborators of Lander Egaña-Gorroño. A scholar is included among the top collaborators of Lander Egaña-Gorroño based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lander Egaña-Gorroño. Lander Egaña-Gorroño is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Egaña-Gorroño, Lander, Dippal Parikh, Gustavo H. Oliveira‐Paula, et al.. (2021). PLX3397, a CSF1 receptor inhibitor, limits allotransplantation-induced vascular remodelling. Cardiovascular Research. 118(12). 2718–2731. 7 indexed citations
2.
Manigrasso, Michaele B., Piul S. Rabbani, Lander Egaña-Gorroño, et al.. (2021). Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice. Science Translational Medicine. 13(621). eabf7084–eabf7084. 54 indexed citations
3.
López‐Díez, Raquel, et al.. (2021). Diabetes and Cardiovascular Complications: The Epidemics Continue. Current Cardiology Reports. 23(7). 74–74. 13 indexed citations
4.
MacLean, Michael, Lander Egaña-Gorroño, Raquel López‐Díez, et al.. (2021). Inflammation Meets Metabolism Roles: for the Receptor for Advanced Glycation End Products Axis in Cardiovascular Disease. PubMed. 3(3). 14 indexed citations
5.
López‐Díez, Raquel, Lander Egaña-Gorroño, Jian–Hua Liu, et al.. (2020). RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism. JCI Insight. 5(13). 45 indexed citations
6.
Egaña-Gorroño, Lander, Raquel López‐Díez, Gautham Yepuri, et al.. (2020). Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models. Frontiers in Cardiovascular Medicine. 7. 37–37. 151 indexed citations
7.
Parikh, Dippal, et al.. (2020). Allograft inflammatory factor-1-like is not essential for age dependent weight gain or HFD-induced obesity and glucose insensitivity. Scientific Reports. 10(1). 3594–3594. 10 indexed citations
8.
Egaña-Gorroño, Lander, Prameladevi Chinnasamy, Isabel Casimiro, et al.. (2019). Allograft inflammatory factor-1 supports macrophage survival and efferocytosis and limits necrosis in atherosclerotic plaques. Atherosclerosis. 289. 184–194. 22 indexed citations
9.
Tort, Olivia, Tuixent Escribà, Lander Egaña-Gorroño, et al.. (2018). Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed. Journal of Lipid Research. 59(11). 2108–2115. 12 indexed citations
10.
Riascos‐Bernal, Dario F., Prameladevi Chinnasamy, Lander Egaña-Gorroño, et al.. (2017). Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury. Arteriosclerosis Thrombosis and Vascular Biology. 37(5). 879–888. 17 indexed citations
11.
Egaña-Gorroño, Lander, Alberto C. Guardo, Tuixent Escribà, et al.. (2016). MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression. PLoS ONE. 11(5). e0155245–e0155245. 19 indexed citations
12.
Guardo, Alberto C., María J. Maleno, Lander Egaña-Gorroño, et al.. (2016). Utility of Systematic Isolation of immune cell subsets from HIV-infected individuals for miRNA profiling. Journal of Immunological Methods. 442. 12–19. 7 indexed citations
13.
Egaña-Gorroño, Lander, Tuixent Escribà, Nicolas Boulanger, et al.. (2014). Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors. PLoS ONE. 9(9). e106360–e106360. 46 indexed citations
14.
Egaña-Gorroño, Lander, Estebán Martínez, Ignacio Pérez, et al.. (2014). Contribution of genetic background and antiretroviral therapy to body fat changes in antiretroviral-naive HIV-infected adults. Journal of Antimicrobial Chemotherapy. 69(11). 3076–3084. 9 indexed citations
15.
Egaña-Gorroño, Lander, Estebán Martínez, Peré Domingo, et al.. (2014). Differential Subcutaneous Adipose Tissue Gene Expression Patterns in a Randomized Clinical Trial of Efavirenz or Lopinavir-Ritonavir in Antiretroviral-Naive Patients. Antimicrobial Agents and Chemotherapy. 58(11). 6717–6723. 3 indexed citations
16.
Egaña-Gorroño, Lander, Estebán Martínez, Tuixent Escribà, et al.. (2012). Association study of lipoprotein(a) genetic markers, traditional risk factors, and coronary heart disease in HIV-1-infected patients. Frontiers in Immunology. 3. 367–367. 2 indexed citations
17.
Egaña-Gorroño, Lander, Estebán Martínez, Bru Cormand, et al.. (2012). Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy. AIDS. 27(4). 529–538. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saskia N. van der Crabben Breakdown of academic impact, for papers by D. Virgil Alfaro Breakdown of academic impact, for papers by Eleni Ritou Breakdown of academic impact, for papers by M.F. Dumon Breakdown of academic impact, for papers by Kerem Bulut Breakdown of academic impact, for papers by H Narbonne Breakdown of academic impact, for papers by Sandra Winning Breakdown of academic impact, for papers by Rivka Lederman Breakdown of academic impact, for papers by Hangxiang Zhang Breakdown of academic impact, for papers by Laurie Bernstein
Rankless by CCL
2026